Bariatric endoscopy has emerged as a therapeutic option for patients with obesity, helping fill the gap between medical treatment and bariatric surgery. Cleveland Clinic recently has begun a bariatric endoscopy program that is integrated into the institution’s multispecialty bariatric weight loss initiatives.
Findings add more to the discussion about how to classify and treat obesity.
The inaugural presentation from EMI Live illustrates how research can guide treatment, but moving from bench to bedside isn’t always the easiest.
Prior research has reinforced obesity as a major risk factor for poor outcomes in patients with COVID-19. Now, a study conducted at Cleveland Clinic has shown that bariatric surgery may substantially improve the prognosis for these patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
One of the more impactful and proactive ways to reduce a patient’s chronic pain is through diet changes.
After an extensive search for a chief of Cleveland Clinic’s Bariatric and Metabolic Institute, Ali Aminian, MD, was named to the leadership position.
Because of the increased risk for severe COVID-19 associated with obesity, it is more important than ever for physicians to keep a close eye on these patients.
Targeting the protein hepsin may be a viable option for treating diabetes.
Despite the increasing proportion of pediatric patients with obesity, there is little data about pain sensitivity and analgesic requirements in this population. A new study finds no significant association between increased BMI and higher perioperative pain scores in pediatric patients, and suggests weight-based analgesic dosing is prudent.
Prompted by the pandemic, the Endocrinology & Metabolism Institute transitioned outpatient visits to telemedicine in a matter of days. In this article, institute leadership discusses the transition and what their practice might look like after COVID-19.